CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $41,000 | +13.9% | 2,680 | -5.3% | 0.01% | -11.1% |
| Q3 2020 | $36,000 | -25.0% | 2,830 | 0.0% | 0.01% | -30.8% |
| Q2 2020 | $48,000 | +26.3% | 2,830 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $38,000 | -17.4% | 2,830 | 0.0% | 0.01% | +8.3% |
| Q4 2019 | $46,000 | -11.5% | 2,830 | 0.0% | 0.01% | -20.0% |
| Q3 2019 | $52,000 | -21.2% | 2,830 | -5.0% | 0.02% | -16.7% |
| Q2 2019 | $66,000 | 0.0% | 2,980 | -9.1% | 0.02% | -5.3% |
| Q1 2019 | $66,000 | +50.0% | 3,280 | 0.0% | 0.02% | +26.7% |
| Q4 2018 | $44,000 | -45.0% | 3,280 | 0.0% | 0.02% | -37.5% |
| Q3 2018 | $80,000 | -34.4% | 3,280 | -47.8% | 0.02% | -36.8% |
| Q2 2018 | $122,000 | -99.8% | 6,280 | 0.0% | 0.04% | +52.0% |
| Q1 2018 | $77,748,000 | +834.0% | 6,280 | +823.5% | 0.02% | +733.3% |
| Q4 2017 | $8,324,000 | -10.6% | 680 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,310,000 | -11.0% | 680 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,465,000 | -16.3% | 680 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $12,506,000 | – | 680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |